Chang YL - Search Results

1

The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.

Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM. Chang CH, et al. Among authors: chang yl. Breast. 2022 Feb;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29. Breast. 2022. PMID: 34894465 Free PMC article.

2

Diffuse alveolar damage associated with ticlopidine use: a case report.

Oon PC, Jerng JS, Kao HL, Chang YL, Yu CJ, Yang PC. Oon PC, et al. Among authors: chang yl. J Formos Med Assoc. 2003 Apr;102(4):262-5. J Formos Med Assoc. 2003. PMID: 12833191

3

Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response.

Wu JY, Wu SG, Yang CH, Gow CH, Chang YL, Yu CJ, Shih JY, Yang PC. Wu JY, et al. Among authors: chang yl. Clin Cancer Res. 2008 Aug 1;14(15):4877-82. doi: 10.1158/1078-0432.CCR-07-5123. Clin Cancer Res. 2008. PMID: 18676761

4

Epidermal growth factor receptor mutations in small cell lung cancer: a brief report.

Shiao TH, Chang YL, Yu CJ, Chang YC, Hsu YC, Chang SH, Shih JY, Yang PC. Shiao TH, et al. Among authors: chang yl, chang yc, chang sh. J Thorac Oncol. 2011 Jan;6(1):195-8. doi: 10.1097/JTO.0b013e3181f94abb. J Thorac Oncol. 2011. PMID: 21178714 Free article.

5

Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma.

Tsai TH, Wu SG, Chang YL, Wu CT, Tsai MF, Wei PF, Yang CH, Yu CJ, Yang PC, Shih JY. Tsai TH, et al. Among authors: chang yl. J Thorac Oncol. 2012 Jun;7(6):993-1000. doi: 10.1097/JTO.0b013e31824cc46b. J Thorac Oncol. 2012. PMID: 22525557 Free article.

6

Unusual presentation of lymphoepithelioma-like carcinoma of lung as a thin-walled cavity.

Hsieh MS, Wu CT, Chang YL. Hsieh MS, et al. Among authors: chang yl. Ann Thorac Surg. 2013 Nov;96(5):1857-9. doi: 10.1016/j.athoracsur.2013.03.021. Ann Thorac Surg. 2013. PMID: 24182474

7

Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study.

Lin CC, Shih JY, Yu CJ, Ho CC, Liao WY, Lee JH, Tsai TH, Su KY, Hsieh MS, Chang YL, Bai YY, Huang DD, Thress KS, Yang JC. Lin CC, et al. Among authors: chang yl. Lancet Respir Med. 2018 Feb;6(2):107-116. doi: 10.1016/S2213-2600(17)30480-0. Epub 2017 Dec 14. Lancet Respir Med. 2018. PMID: 29249325

8

Diffuse pulmonary infiltrates after bone marrow transplantation: the role of open lung biopsy.

Wang JY, Chang YL, Lee LN, Chen JH, Tang JL, Yang PC, Lee YC. Wang JY, et al. Among authors: chang yl. Ann Thorac Surg. 2004 Jul;78(1):267-72. doi: 10.1016/j.athoracsur.2004.03.002. Ann Thorac Surg. 2004. PMID: 15223441 Review.

9

Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern.

Wu SG, Chang YL, Hsu YC, Wu JY, Yang CH, Yu CJ, Tsai MF, Shih JY, Yang PC. Wu SG, et al. Among authors: chang yl. Oncologist. 2008 Dec;13(12):1276-84. doi: 10.1634/theoncologist.2008-0093. Epub 2008 Dec 5. Oncologist. 2008. PMID: 19060236 Free article.

10

Surgical treatment of organising pneumonia mimicking lung cancer: experience of 27 patients.

Wu CT, Chang YL, Chen WC, Lee YC. Wu CT, et al. Among authors: chang yl. Eur J Cardiothorac Surg. 2010 Apr;37(4):797-801. doi: 10.1016/j.ejcts.2009.11.002. Epub 2009 Dec 1. Eur J Cardiothorac Surg. 2010. PMID: 19954998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,247 results

Search Page